Annual D&A
$6.49 M
-$277.00 K-4.09%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual depreciation & amortization is $6.49 million, with the most recent change of -$277.00 thousand (-4.09%) on December 31, 2023.
- During the last 3 years, BBIO annual D&A has risen by +$5.04 million (+346.02%).
- BBIO annual D&A is now -4.09% below its all-time high of $6.77 million, reached on December 31, 2022.
Performance
BBIO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.54 M
-$36.00 K-2.29%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly depreciation & amortization is $1.54 million, with the most recent change of -$36.00 thousand (-2.29%) on September 30, 2024.
- Over the past year, BBIO quarterly D&A has dropped by -$47.00 thousand (-2.97%).
- BBIO quarterly D&A is now -55.88% below its all-time high of $3.49 million, reached on June 30, 2021.
Performance
BBIO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$6.29 M
-$101.00 K-1.58%
September 30, 2024
Summary
- As of February 7, 2025, BBIO TTM depreciation & amortization is $6.29 million, with the most recent change of -$101.00 thousand (-1.58%) on September 30, 2024.
- Over the past year, BBIO TTM D&A has dropped by -$201.00 thousand (-3.10%).
- BBIO TTM D&A is now -12.12% below its all-time high of $7.16 million, reached on March 31, 2022.
Performance
BBIO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
BBIO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.1% | -3.0% | -3.1% |
| 3 y3 years | +346.0% | -3.0% | -3.1% |
| 5 y5 years | +100.0% | -3.0% | -3.1% |
BBIO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.1% | +11.1% | -18.4% | +0.8% | -12.1% | +19.7% |
| 5 y | 5-year | -4.1% | +656.0% | -55.9% | +251.5% | -12.1% | +1063.2% |
| alltime | all time | -4.1% | -100.0% | -55.9% | +251.5% | -12.1% | -100.0% |
BridgeBio Pharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.54 M(-2.3%) | $6.29 M(-1.6%) |
| Jun 2024 | - | $1.57 M(-1.4%) | $6.39 M(-1.0%) |
| Mar 2024 | - | $1.60 M(+0.7%) | $6.46 M(-0.6%) |
| Dec 2023 | $6.49 M(-4.1%) | $1.58 M(-3.3%) | $6.49 M(-1.1%) |
| Sep 2023 | - | $1.64 M(+0.1%) | $6.57 M(-0.1%) |
| Jun 2023 | - | $1.64 M(+0.2%) | $6.58 M(+0.8%) |
| Mar 2023 | - | $1.63 M(-1.6%) | $6.52 M(-3.7%) |
| Dec 2022 | $6.77 M(+15.9%) | $1.66 M(+0.9%) | $6.77 M(+2.0%) |
| Sep 2022 | - | $1.65 M(+4.0%) | $6.64 M(+26.3%) |
| Jun 2022 | - | $1.58 M(-16.0%) | $5.26 M(-26.6%) |
| Mar 2022 | - | $1.88 M(+23.5%) | $7.16 M(+22.6%) |
| Dec 2021 | $5.84 M | $1.53 M(+475.8%) | $5.84 M(+23.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $265.00 K(-92.4%) | $4.75 M(+36.9%) |
| Jun 2021 | - | $3.49 M(+515.9%) | $3.47 M(+134.4%) |
| Mar 2021 | - | $566.00 K(+30.1%) | $1.48 M(+1.7%) |
| Dec 2020 | $1.46 M(+69.5%) | $435.00 K(-142.9%) | $1.46 M(+42.6%) |
| Sep 2020 | - | -$1.01 M(-167.9%) | $1.02 M(-49.9%) |
| Jun 2020 | - | $1.50 M(+176.3%) | $2.04 M(+276.3%) |
| Mar 2020 | - | $541.00 K(-473.1%) | $541.00 K(>+9900.0%) |
| Dec 2019 | $859.00 K(>+9900.0%) | - | - |
| Dec 2018 | $0.00 | -$145.00 K(-288.3%) | $0.00(-100.0%) |
| Sep 2018 | - | $77.00 K(+83.3%) | $145.00 K(+113.2%) |
| Jun 2018 | - | $42.00 K(+61.5%) | $68.00 K(+161.5%) |
| Mar 2018 | - | $26.00 K | $26.00 K |
FAQ
- What is BridgeBio Pharma annual depreciation & amortization?
- What is the all time high annual D&A for BridgeBio Pharma?
- What is BridgeBio Pharma annual D&A year-on-year change?
- What is BridgeBio Pharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly D&A year-on-year change?
- What is BridgeBio Pharma TTM depreciation & amortization?
- What is the all time high TTM D&A for BridgeBio Pharma?
- What is BridgeBio Pharma TTM D&A year-on-year change?
What is BridgeBio Pharma annual depreciation & amortization?
The current annual D&A of BBIO is $6.49 M
What is the all time high annual D&A for BridgeBio Pharma?
BridgeBio Pharma all-time high annual depreciation & amortization is $6.77 M
What is BridgeBio Pharma annual D&A year-on-year change?
Over the past year, BBIO annual depreciation & amortization has changed by -$277.00 K (-4.09%)
What is BridgeBio Pharma quarterly depreciation & amortization?
The current quarterly D&A of BBIO is $1.54 M
What is the all time high quarterly D&A for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly depreciation & amortization is $3.49 M
What is BridgeBio Pharma quarterly D&A year-on-year change?
Over the past year, BBIO quarterly depreciation & amortization has changed by -$47.00 K (-2.97%)
What is BridgeBio Pharma TTM depreciation & amortization?
The current TTM D&A of BBIO is $6.29 M
What is the all time high TTM D&A for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM depreciation & amortization is $7.16 M
What is BridgeBio Pharma TTM D&A year-on-year change?
Over the past year, BBIO TTM depreciation & amortization has changed by -$201.00 K (-3.10%)